| Dr Roberto Nonesupplied Zamudio, MD | |
|
301 University Blvd, Galveston, TX 77555-0462 | |
| (409) 772-4194 | |
| Not Available |
| Full Name | Dr Roberto Nonesupplied Zamudio |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 301 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033313630 | NPI | - | NPPES |
| 3851440300 | Other | MYUTMB 3851440300-COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | BP1-0026586 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Dignity Health Arizona General Hospital | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chandler Radiology Associates Llc | 4183600877 | 41 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new University of Saskatchewan training program that will produce future leaders in food safety, infectious disease control and public policy has been awarded $1.65 million over six years through the Natural Sciences and Engineering Research Council's Collaborative Research and Training Experience (CREATE) program.
The evidence linking amateur boxing and chronic traumatic brain injury is not strong, concludes a study published on bmj.com today.
As predicted, the last-ditch GOP effort to "repeal and replace" the Affordable Care Act ended the way its predecessors did this week — in failure.
Exhibit and events to highlight High definition Dynamic Radiosurgery with Versa HD and Monaco treatment planning software.
› Verified 6 days ago
| Entity Name | Chandler Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386602076 PECOS PAC ID: 4183600877 Enrollment ID: O20040624001184 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new University of Saskatchewan training program that will produce future leaders in food safety, infectious disease control and public policy has been awarded $1.65 million over six years through the Natural Sciences and Engineering Research Council's Collaborative Research and Training Experience (CREATE) program.
The evidence linking amateur boxing and chronic traumatic brain injury is not strong, concludes a study published on bmj.com today.
As predicted, the last-ditch GOP effort to "repeal and replace" the Affordable Care Act ended the way its predecessors did this week — in failure.
Exhibit and events to highlight High definition Dynamic Radiosurgery with Versa HD and Monaco treatment planning software.
› Verified 6 days ago
| Entity Name | Az-tech Radiology & Open Mri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710199658 PECOS PAC ID: 1951356799 Enrollment ID: O20070518000525 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new University of Saskatchewan training program that will produce future leaders in food safety, infectious disease control and public policy has been awarded $1.65 million over six years through the Natural Sciences and Engineering Research Council's Collaborative Research and Training Experience (CREATE) program.
The evidence linking amateur boxing and chronic traumatic brain injury is not strong, concludes a study published on bmj.com today.
As predicted, the last-ditch GOP effort to "repeal and replace" the Affordable Care Act ended the way its predecessors did this week — in failure.
Exhibit and events to highlight High definition Dynamic Radiosurgery with Versa HD and Monaco treatment planning software.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberto Nonesupplied Zamudio, MD 6424 Central City Blvd Apt 221, Galveston, TX 77551-2066 Ph: () - | Dr Roberto Nonesupplied Zamudio, MD 301 University Blvd, Galveston, TX 77555-0462 Ph: (409) 772-4194 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new University of Saskatchewan training program that will produce future leaders in food safety, infectious disease control and public policy has been awarded $1.65 million over six years through the Natural Sciences and Engineering Research Council's Collaborative Research and Training Experience (CREATE) program.
The evidence linking amateur boxing and chronic traumatic brain injury is not strong, concludes a study published on bmj.com today.
As predicted, the last-ditch GOP effort to "repeal and replace" the Affordable Care Act ended the way its predecessors did this week — in failure.
Exhibit and events to highlight High definition Dynamic Radiosurgery with Versa HD and Monaco treatment planning software.
› Verified 6 days ago
Dr. Alvin Carlos Camacho, MD Radiology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-4194 | |
Morton H. Leonard Jr., M.D. Radiology Medicare: Medicare Enrolled Practice Location: 38 Lakeview Dr, Galveston, TX 77551 Phone: 409-692-3345 | |
Faustino C. Guinto Jr., M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Dr. Eric Michael Walser, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Department Of Radiology, 301 University Blvd, Galveston, TX 77555 Phone: 409-747-0100 Fax: 409-772-8219 | |
Gregory Chaljub, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Tomas Eduardo Uribe Acosta, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |